Suppr超能文献

2 型糖尿病增强了脉压与慢性肾脏病之间的关联:AusDiab 研究。

Type 2 diabetes strengthens the association between pulse pressure and chronic kidney disease: the AusDiab study.

机构信息

Department of Epidemiology and Biostatistics and the EMGO Institute for Health and Care Research, VU University Medical Center, Van der Boechorststraat 7, 1081 BT Amsterdam, The Netherlands.

出版信息

J Hypertens. 2011 May;29(5):953-60. doi: 10.1097/HJH.0b013e328344d9cf.

Abstract

OBJECTIVE

Chronic kidney disease (CKD) is a serious disorder with significant public health impact. Identification of factors associated with risk of progression of kidney disease may help in earlier intervention in high-risk groups. We investigated whether brachial pulse pressure (PP) was associated with 5-year changes in estimated glomerular filtration rate (eGFR) and incident CKD and whether type 2 diabetes modified these associations.

METHODS

In the population-based Australian Diabetes, Obesity and Lifestyle Study (AusDiab) 5554 individuals (5.8% with type 2 diabetes) who took part in the 5-year follow-up and had no CKD or microalbuminuria at baseline were included.

RESULTS

After adjusting for baseline age, sex, eGFR and use of blood pressure-lowering medication, each baseline SD higher PP was associated with a decline in eGFR of 0.32 ml/min (P=0.006) and an odds ratio (OR) for CKD of 1.29 [95% confidence interval (CI) 1.09-1.53] in individuals without type 2 diabetes. In individuals with type 2 diabetes, eGFR declined by 1.10 ml/min (P=0.011) and the OR for incident CKD was 1.94 (1.14-3.29). Similar associations with eGFR decline were observed with systolic blood pressure and incident CKD in individuals without type 2 diabetes. In individuals with type 2 diabetes, higher systolic blood pressure was only significantly associated with eGFR decline if the diastolic blood pressure was 70 mmHg or less (P for interaction between systolic and diastolic blood pressure: 0.033).

CONCLUSIONS

PP is an important risk factor for eGFR decline and incident CKD over a 5-year period, especially in individuals with type 2 diabetes.

摘要

目的

慢性肾脏病(CKD)是一种严重的疾病,对公共健康有重大影响。识别与肾脏疾病进展风险相关的因素,可能有助于对高危人群进行早期干预。我们研究了肱动脉脉搏压(PP)是否与 5 年内估算肾小球滤过率(eGFR)的变化以及 CKD 的发生有关,以及 2 型糖尿病是否改变了这些关联。

方法

在基于人群的澳大利亚糖尿病、肥胖和生活方式研究(AusDiab)中,纳入了 5554 名参加了 5 年随访且基线时无 CKD 或微量白蛋白尿的个体(2 型糖尿病患者占 5.8%)。

结果

在校正了基线年龄、性别、eGFR 和使用降压药物后,每个基线 SD 更高的 PP 与 eGFR 的下降相关,下降 0.32 ml/min(P=0.006),无 2 型糖尿病个体的 CKD 比值比(OR)为 1.29(95%置信区间 [CI] 1.09-1.53)。在 2 型糖尿病患者中,eGFR 下降 1.10 ml/min(P=0.011),新发 CKD 的 OR 为 1.94(1.14-3.29)。在无 2 型糖尿病患者中,收缩压与 eGFR 下降和新发 CKD 也存在类似的关联。在 2 型糖尿病患者中,如果舒张压为 70 mmHg 或更低,较高的收缩压仅与 eGFR 下降显著相关(收缩压和舒张压之间的交互作用的 P 值:0.033)。

结论

PP 是 eGFR 下降和 5 年内新发 CKD 的重要危险因素,尤其是在 2 型糖尿病患者中。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验